Publications
For a full list of our publications, please visit PubMed.
- Cai Q, Zhang Z, Cui X, Zeng C, Cai J, Cai J, Wu K, Zhang X, Shi Y, Arvanitakis Z et al. PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines. Database (Oxford) 2023 Jun 10;2023. pii:baad042
- Cai Q, Zhang Z, Cui X, Zeng C, Cai J, Cai J, Wu K, Zhang X, Shi Y, Arvanitakis Z et al. PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines. Database (Oxford) 2023 Jun 10;2023. pii:baad042
- Getu AA, Zhou M, Cheng SY, Tan M The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy. Cancer Lett 2023 Jun 01;563:216183. doi:10.1016/j.canlet.2023.216183
- Goenka A, Song X, Tiek D, Iglesia RP, Lu M, Zeng C, Horbinski C, Zhang W, Hu B, Cheng SY Oncogenic Long Non-coding RNA LINC02283 Enhances PDGF Receptor A mediated Signaling and Drives Glioblastoma Tumorigenesis. Neuro Oncol 2023 Mar 29;. pii:noad065
- McCord M, Bartom E, Burdett K, Baran A, Eckerdt FD, Balyasnikova IV, McCortney K, Sears T, Cheng SY, Sarkaria JN et al. Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts. Cancers (Basel) 2022 Nov 09;14(22). pii:5494
- Goenka A, Cheng SY Targeting neddylation in cancer. Neuro Oncol 2022 Nov 02;24(11):1869-1870. doi:10.1093/neuonc/noac159
- Goenka A, Tiek DM, Song X, Iglesia RP, Lu M, Hu B, Cheng SY The Role of Non-Coding RNAs in Glioma. Biomedicines 2022 Aug 20;10(8). pii:2031
- Tiek DM, Erdogdu B, Razaghi R, Jin L, Sadowski N, Alamillo-Ferrer C, Hogg JR, Haddad BR, Drewry DH, Wells CI et al. Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas. Sci Adv 2022 Jun 24;8(25):eabn3471. pii:eabn3471
- Iglesia RP, Prado MB, Alves RN, Escobar MIM, Fernandes CFL, Fortes ACDS, Souza MCDS, Boccacino JM, Cangiano G, Soares SR et al. Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progression. Front Cell Dev Biol 2022;10:907423. pii:907423
- Tiek D, Cheng SY DNA damage and metabolic mechanisms of cancer drug resistance. Cancer Drug Resist 2022;5(2):368-379. doi:10.20517/cdr.2021.148
- Tiek DM, Cheng SY New life for an old therapy: ELTD1 as a downstream target of angiogenesis. Neuro Oncol 2022 Mar 12;24(3):412-413. doi:10.1093/neuonc/noab286
- Yu B, Luo F, Sun B, Liu W, Shi Q, Cheng SY, Chen C, Chen G, Li Y, Feng H KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer. Adv Sci (Weinh) 2021 Oct;8(20):e2100014. pii:2100014
- Song L, Lin C, Gong H, Wang C, Liu L, Wu J, Tao S, Hu B, Cheng SY, Li M et al. Author Correction: miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops. Cell Res 2021 Oct;31(10):1138. doi:10.1038/s41422-021-00549-y
- Cai J, Zeng C, Hua W, Qi Z, Song Y, Lu X, Li D, Zhang Z, Cui X, Zhang X et al. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas. Neurooncol Adv 2021;3(1):vdab049. pii:vdab049
- Huang T, Cheng SY Targeting phospholipid metabolism for glioblastoma therapy. Neuro Oncol 2021 Mar 25;23(3):343-344. doi:10.1093/neuonc/noaa309
- Huang T, Yang Y, Song X, Wan X, Wu B, Sastry N, Horbinski CM, Zeng C, Tiek D, Goenka A et al. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. Mol Cell 2021 Mar 18;81(6):1276-1291.e9. doi:10.1016/j.molcel.2021.01.015
- Gao X, Xia X, Li F, Zhang M, Zhou H, Wu X, Zhong J, Zhao Z, Zhao K, Liu D et al. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nat Cell Biol 2021 Mar;23(3):278-291. doi:10.1038/s41556-021-00639-4
- Goenka A, Tiek D, Song X, Huang T, Hu B, Cheng SY The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma. Cells 2021 Feb 24;10(3). pii:484
- Luo JH, Liu S, Tao J, Ren BG, Luo K, Chen ZH, Nalesnik M, Cieply K, Ma T, Cheng SY et al. Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings. Oncogene 2021 Feb;40(6):1064-1076. doi:10.1038/s41388-020-01582-8
- Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy 2021 Jan;17(1):1-382. doi:10.1080/15548627.2020.1797280
- Sastry NG, Wan X, Huang T, Alvarez AA, Pangeni RP, Song X, James CD, Horbinski CM, Brennan CW, Nakano I et al. LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement. Neuro Oncol 2020 Sep 29;22(9):1315-1326. doi:10.1093/neuonc/noaa032
- Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, Sastry N, Hu B, Cheng SY Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics 2020;10(19):8721-8743. doi:10.7150/thno.41648
- Nayak S, Mahenthiran A, Yang Y, McClendon M, Mania-Farnell B, James CD, Kessler JA, Tomita T, Cheng SY, Stupp SI et al. Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application. Cancers (Basel) 2020 Feb 24;12(2). pii:516